AUSSENDER



Formycon AG
Ansprechpartner: Sabrina Müller
Tel.: +49 89 864667-149
E-Mail: Sabrina.Mueller@formycon.com
Pressefach (48)

Rechtsgrundlage

Alle
Insiderinformationen
Unternehmensmitteilungen
Finanzberichte
Stimmrechtsmitteilungen
HV-Bekanntmachungen
Sonstige

Schlagwörter

Directors' Dealings
Eigengeschäfte von Führungskräften
Formycon AG
DE EN
15.11.2019 - 20:05 | Formycon AG
Managers' transactions announcement according to article 19 MAR
06.11.2019 - 22:05 | Formycon AG
Bioeq IP AG exclusively licenses US Marketing Rights for FYB201 to Coherus BioSciences, Inc.
26.07.2019 - 19:00 | Formycon AG
Managers' transactions announcement according to article 19 MAR
26.07.2019 - 19:00 | Formycon AG
Managers' transactions announcement according to article 19 MAR
26.06.2019 - 18:15 | Formycon AG
Formycon Reports Further Course of Capital Measure
26.06.2019 - 17:34 | Formycon AG
Managers' transactions announcement according to article 19 MAR
07.06.2019 - 19:30 | Formycon AG
Managers' transactions announcement according to article 19 MAR
03.06.2019 - 22:50 | Formycon AG
Formycon Reports Latest Status of Capital Increase
22.03.2019 - 19:00 | Formycon AG
Formycon Places Cash Capital Increase of EUR 17.3 Million with Institutional Investor
11.08.2018 - 20:05 | Formycon AG
Managers' transactions announcement according to article 19 MAR
11.08.2018 - 20:00 | Formycon AG
Managers' transactions announcement according to article 19 MAR
23.07.2018 - 20:05 | Formycon AG
Managers' transactions announcement according to article 19 MAR
23.07.2018 - 20:00 | Formycon AG
Managers' transactions announcement according to article 19 MAR
02.05.2018 - 07:00 | Formycon AG
Biosimilar Candidate FYB201 Shows Efficacy Comparable to the Reference Product in Phase III Study
22.12.2017 - 07:30 | Formycon AG
Formycon and Aristo Pharma are Founding a Joint Venture for the Development of FYB202
|
99.085 Abonnenten
|
234.545 Meldungen
|
94.982 Pressefotos
|
Folgen Sie uns auf Twitter
|
Persönlicher Kontakt